Author Correction: Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance (Nature Communications, (2022), 13, 1, (4739), 10.1038/s41467-022-32485-9)

Y Deng; ST Diepstraten; MA Potts; G Giner; S Trezise; AP Ng; G Healey; SR Kane; A Cooray; K Behrens; A Heidersbach; AJ Kueh; M Pal; S Wilcox; L Tai; WS Alexander; JE Visvader; SL Nutt; A Strasser; B Haley; Q Zhao; GL Kelly; MJ Herold

Journal article

Author Correction: Generation of a CRISPR activation mouse that enables modelling of aggressive lymphoma and interrogation of venetoclax resistance (Nature Communications, (2022), 13, 1, (4739), 10.1038/s41467-022-32485-9)

Y Deng, ST Diepstraten, MA Potts, G Giner, S Trezise, AP Ng, G Healey, SR Kane, A Cooray, K Behrens, A Heidersbach, AJ Kueh, M Pal, S Wilcox, L Tai, WS Alexander, JE Visvader, SL Nutt, A Strasser, B Haley Show all

Nature Communications | Published : 2022

DOI: 10.1038/s41467-022-32817-9

Download PDF

Abstract

In this article the affiliation details for Amy Heidersbach were incorrectly given as ‘School of Dentistry and Medical Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia’ but should have been ‘Department ofMolecular Biology, Genentech, Inc., South San Francisco, CA, USA’. The original article has been corrected.